Roth Capital Starts Intec Pharma Ltd. (NTEC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Maxim Group Starts Intec Pharma Ltd. (NTEC) at Buy
September 15, 2015 5:00 PM EDTMaxim Group initiates coverage on Intec Pharma Ltd. (NASDAQ: NTEC) with a Buy rating and a price target of $9.00.
Analyt Jason Kolbert commented, "In August 2015, Intec Pharmaceuticals completed its IPO, raising approximately $30M. This is enough capital for its Phase III single (505B2... More
